Sandoz announces focus on biosimilars and complex generics

Feb 26, 2020

Sandoz’s US President announced a focus on biosimilars and complex generics as it re-prioritises its US portfolio. As part of the re-prioritisation, Sandoz will sell much of its small molecule generics portfolio to Aurobindo Pharma.

Print Page Mail Article